This topic contains a solution. Click here to go to the answer

Author Question: One prevalent outcome for individuals with schizoid personality disorder is a. homelessness. b. ... (Read 64 times)

stephzh

  • Hero Member
  • *****
  • Posts: 556
One prevalent outcome for individuals with schizoid personality disorder is
 
  a. homelessness.
 b. drug abuse.
 c. eating disorders.
  d. anxiety.

Question 2

A person with paranoid personality disorder may
 
  a. mistrust other people.
 b. get into arguments with people.
  c. be quiet and withdrawn.
 d. all of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dellikani2015

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

a

Answer to Question 2

d




stephzh

  • Member
  • Posts: 556
Reply 2 on: Jun 22, 2018
Thanks for the timely response, appreciate it


vickybb89

  • Member
  • Posts: 347
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library